A New Dawn for IBS Treatment: Targeting the Brain for relief Irritable bowel syndrome (IBS) affects over 10% of the global population, causing meaningful discomfort and impacting quality of life. While current treatments primarily focus on symptom management, a groundbreaking study published in the British Journal of Pharmacology offers a glimmer of hope: targeting the … Read more
Archyde Could Opioid Drugs Offer Relief for Irritable bowel Syndrome? Table of Contents 1. Could Opioid Drugs Offer Relief for Irritable bowel Syndrome? 2. Could DOP agonists Offer Lasting Relief for IBS? 3. A New Approach to IBS Treatment 4. Understanding the brain-Gut Connection 5. Targeting the Insular Cortex 6. Promising Future for IBS Patients … Read more
Irritable bowel syndrome (IBS) is a common digestive disorder that affects the intestine, causing symptoms such as abdominal pain, bloating, gas, and changes in bowel habits, including diarrhea, constipation, or both. Although this condition affects about a tenth of the global population, the underlying causes and mechanisms of IBS remain unclear. Consequently, treatments for IBS … Read more
The Sudan virus, a close relative of Ebola, has a fatality rate of 50% but remains poorly understood in terms of how it infects cells. Currently, no approved treatments exist. To address this critical gap in pandemic preparedness, researchers at the University of Minnesota and the Midwest Antiviral Drug Discovery (AViDD) Center investigated how this … Read more
The global burden of anxiety- and depression-related disorders is on the rise. While multiple drugs have been developed to treat these conditions, current medications have several limitations, including slow action and adverse effects with long-term use. This underscores the urgent need for novel, rapidly-acting therapeutic agents with minimal side effects. The delta opioid receptor (DOP) … Read more